Drugs / Biosimilar recombinant FSH
last change Jun 2016 re-read 2 minutes ago

Biosimilar recombinant FSH

Protein / enzyme biologic

Developed for
infertility disorder

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02503605 Comparator Oct 2015 → Mar 2016 infertility disorder IVI Madrid Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Biosimilar recombinant FSH ClinicalTrials.gov intervention name — accepted as the source's own label NCT02503605
Modality Protein / enzyme biologic “Biosimilar products are drugs "like" biotechnological origin to other innovative biological medicines” NCT02503605